science
plus
.abes.fr
|
explorer
À propos de :
http://hub.abes.fr/bmj/periodical/gut/2013/volume_62/issue_5/w
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
bibo:Issue
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
work
Issue
New Facet based on Instances of this Class
Attributs
Valeurs
type
work
Issue
Is Part Of
http://hub.abes.fr/bmj/periodical/gut/2013/volume_62
has manifestation of work
http://hub.abes.fr/bmj/periodical/gut/2013/volume_62/issue_5/m/print
http://hub.abes.fr/bmj/periodical/gut/2013/volume_62/issue_5/m/web
Date Copyrighted
2013
Rights
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
issue
5
Access Rights
open-access
is
Is Part Of
of
Systemic treatment of advanced pancreatic cancer—step by step progress
Acute variceal bleeding in a man with coeliac disease
Exploring life before IBD
Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study
The intermediate filament protein, vimentin, is a regulator of NOD2 activity
A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation
Selectin binding is essential for peritoneal carcinomatosis in a xenograft model of human pancreatic adenocarcinoma in pfp−−/rag2−− mice
Serological markers predict inflammatory bowel disease years before the diagnosis
About ischaemic heart disease in inflammatory bowel disease: some considerations
Acceleration in colorectal carcinogenesis: the hare, the tortoise or myth?
The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention
Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the ‘Arbeitsgemeinschaft Internistische Onkologie’ (AIO-PK0104)
Secukinumab failure in Crohn's disease: the yeast connection?
microRNA-145 in Barrett's oesophagus: regulating BMP4 signalling via GATA6
Vitamin B12 supplementation improves rates of sustained viral response in patients chronically infected with hepatitis C virus
Cell and organ bioengineering technology as applied to gastrointestinal diseases
Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis
An update on the use and investigation of probiotics in health and disease
miR-574-5p negatively regulates Qki6/7 to impact β-catenin/Wnt signalling and the development of colorectal cancer
Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
Offering people a choice for colorectal cancer screening
Liver disease progression and virological response: entecavir rescue still possible in the setting of rtM204I lamivudine-resistant mutation
Highlights from this issue
GI highlights from the literature
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata